Multicenter Cohort Study of AAV in Hunan of China
ConditionANCA Associated Vasculitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorXiangya Hospital of Central South University
About this trial
This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.
Eligibility criteria
Qualifiers
Fulfill 2012 criteria of ANCA associated vasculitis and agree to sign informed consent
Disqualifiers
Do not agree to sign informed consent
Trial design
Treatments tested in this trial
- No Intervention
Treatment groups
500 Participants
are divided into 5 treatment groupsSponsors and collaborators
Xiangya Hospital of Central South University
Lead sponsor
Central South University
Collaborator
The Third Xiangya Hospital of Central South University
Collaborator
Hunan Provincial People's Hospital
Collaborator
Xiangtan Central Hospital
Collaborator
Source ClinicalTrials.gov